(S (NP (NP (DT A) (JJ major) (NN challenge)) (PP (IN in) (NP (JJ computational) (NN chemistry)))) (VP (VBZ is) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NP (JJ novel) (JJ molecular) (NNS structures)) (PP (IN with) (NP (JJ desirable) (ADJP (JJ pharmacological) (CC and) (JJ physiochemical)) (NNS properties))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP investigate) (NP (NP (DT the) (JJ potential) (NN use)) (PP (IN of) (NP (NP (NN autoencoder)) (, ,) (NP (DT a) (JJ deep) (NN learning) (NN methodology)) (, ,))) (PP (IN for) (NP (ADJP (FW de) (FW novo)) (JJ molecular) (NN design))))) (. .))
(S (S (NP (JJ Various) (JJ generative) (NNS autoencoders)) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VP (VB map) (NP (NN molecule) (NNS structures)) (PP (IN into) (NP (DT a) (JJ continuous) (JJ latent) (NN space)))) (CC and) (ADVP (NN vice) (NNS versa)))))))) (CC and) (S (NP (NP (PRP$ their) (NN performance)) (PP (IN as) (NP (NN structure) (NN generator)))) (VP (VBD was) (VP (VBN assessed)))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (JJ latent) (NN space)) (VP (VP (VBZ preserves) (NP (JJ chemical) (NN similarity) (NN principle))) (CC and) (ADVP (RB thus)) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (JJ analogue) (NNS structures)))))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (S (NP (NP (DT the) (JJ latent) (NN space)) (VP (VBN created) (PP (IN by) (NP (NNS autoencoders))))) (VP (VBD were) (VP (VBN searched) (ADVP (RB systematically)) (S (VP (TO to) (VP (VB generate) (NP (NP (JJ novel) (NNS compounds)) (PP (IN with) (NP (NP (JJ predicted) (NN activity)) (PP (IN against) (NP (NN dopamine) (NN receptor) (NN type) (CD 2)))))))))))) (CC and) (S (NP (NP (NNS compounds)) (ADJP (JJ similar) (PP (TO to) (NP (NP (VB known) (JJ active) (NNS compounds)) (VP (RB not) (VBN included) (PP (IN in) (NP (DT the) (NN training) (VBN set)))))))) (VP (VBD were) (VP (VBN identified)))) (. .))
